Abstract:The in-stent restenosis (ISR) and the late stent thrombosis (LAST) represent the most common failures of stent implantation and are both mediated at the injured endothelium. The natural endothelium healing mechanism provides an approach to achieve in situ endothelialization of the implant by stimulating the neighboring endothelial cells (ECs) migration or capturing the circulating endothelial cells (CEC) directly from the blood circulation. An anti-CD34 antibody functionalized multilayer of heparin/collagen is developed here via layer-by-layer assemble. The ellipsometry and QCM-D results demonstrate that the multilayer coatings with slight glutaraldehyde cross-linking are stable in static incubation and flushing conditions, respectively. The in vitro hemocompatibility tests and cell culture results indicate that both heparin/collagen multilayers with or without the anti-CD34 antibody functionalization not only preserve good hemocompatibility, but also promote cell attachment and growth notably. While the heparin/collagen multilayer coatings show no selectivity in promotion of ECs and smooth muscle cells (SMCs), the anti-CD34 antibody functionalized heparin/collagen multilayers can specifically promote the attachment and growth of the vascular ECs. The metabolic activity assessment and the NO secretion measurements further indicate that the adherent ECs on the anti-CD34 antibody functionalized heparin/collagen multilayer surface have better viability and possess the specific function of the natural vascular ECs. In vivo experiments indicate that the anti-CD34 antibody can enrich and accelerate the attachment of the vascular cells onto the stent and rapid endothelialization is realized. While no significant difference of neointimal hyperplasia is observed between the bare metal stents and heparin/collagen multilayer modified stents, the neointimal hyperplasia on the anti-CD34 antibody functionalized multilayer modified stents is significantly inhibited. The success of the anti-CD34 antibody functionalized heparin/collagen multilayer coating in rapid endothelialization and anti-restenosis might indicate that the immobilization of ECs specific ligand onto a cytocompatible matrix can be a good approach for in situ endothelialization and a possible solution to ISR.

Study of a Novel Coating Strategy for Coronary Stents: Evaluation of Stainless Metallic Steel Coated with VEGF and Anti-Cd34 Antibody in Vitro.

Study of Novel Coating Strategy for Coronary Stents: Simutaneous Coating of VEGF and Anti- CD34 Antibody.

The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents.

Distinctive Effects of CD34- and CD133-specific Antibody-Coated Stents on Re-Endothelialization and In-Stent Restenosis at the Early Phase of Vascular Injury

Direct Adsorption of Anti-CD34 Antibodies on the Nano-Porous Stent Surface to Enhance Endothelialization.

The Effect of REDV/TiO2 Coating Coronary Stents on In-Stent Restenosis and Re-Endothelialization

Design and Testing of Hydrophobic Core/hydrophilic Shell Nano/micro Particles for Drug-Eluting Stent Coating

Preparation of Vascular Endothelial Cadherin Loaded-Amphoteric Copolymer Decorated Coronary Stents for Anticoagulation and Endothelialization

In Situ Endothelialization of Intravascular Stents Coated with an Anti-Cd34 Antibody Functionalized Heparin-Collagen Multilayer

Construction of Biological Factor-Coated Stent and Its Effect on Promoting Endothelialization

In vitro study of stimulation effect on endothelialization by a copper bearing cobalt alloy.

Performance evaluation of a cerebrovascular stent coated with bone marrow mesenchymal stem cells

Covalent Immobilization of Biomolecules on Stent Materials Through Mussel Adhesive Protein Coating to Form Biofunctional Films.

Endothelium-Mimicking Multifunctional Coating Modified Cardiovascular Stents Via a Stepwise Metal-Catechol-(Amine) Surface Engineering Strategy

Liposomal surface coatings of metal stents for efficient non-viral gene delivery to the injured vasculature

Immobilization of CD34 Antibodies onto 316L Stainless Steel and in vitro Cytocompatibility

Genetically encoded biocompatible anti-coagulant protein-coated coronary artery stents drive endothelialization

A Novel Stent Coated with Antibody Against CD34 Carried by the Degradable Polymer Reduces Restenosis in Canine

Application of a Reactive Oxygen Species-Responsive Drug-Eluting Coating for Surface Modification of Vascular Stents

Vegf-Transfected Human Endothelial Cell Coating On Stents Promotes Re-Endothelization And Inhibits In-Stent Restenosis

Effect of a Novel Stent on Re-Endothelialization, Platelet Adhesion, and Neointimal Formation